-
Product Insights
NewLikelihood of Approval Analysis for Poisoning
Overview How likely is it that the drugs in Poisoning will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Poisoning Overview A poison refers to any substance harmful to the body, whether...
-
Product Insights
NewLikelihood of Approval Analysis for Drug Toxicity
Overview How likely is it that the drugs in Drug Toxicity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Drug Toxicity Overview Drug toxicity' can be defined as a diverse array...
-
Product Insights
ICP Monitoring Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
ICP Monitoring Devices Pipeline Market Report Overview The ICP Monitoring Devices pipeline market research report provides comprehensive information about the ICP Monitoring Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segment ·      External Ventricular Drainage (EVD) Key Territories ·      The US ·      Europe ·      Brazil ·      Canada ·      China ·      India ·      Israel ·      Japan ·      Russia ·      South Africa ·      South...
-
Company Profile
NewHanAll Biopharma Co Ltd – Company Profile
HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for the treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for treating dry eye diseases; HL189 against non-infectious uveitis; IM156 targeting cancers; and HL190 to treat wet age-related macular degeneration. It also sells drugs for treating digestive dysfunction, osteoporosis, liver dysfunction, hepatic coma, metabolic disorders caused due to hypocalcemia,...
Add to Basket -
Product Insights
Inspira Technologies Oxy Bhn Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Inspira Technologies Oxy Bhn Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Inspira Technologies Oxy Bhn Ltd (Inspira Technologies) is a novel medical technology company in the respiratory treatment area. The company is developing respiratory care solutions as an alternative to invasive mechanical ventilation to treat respiratory failure. It developed INSPIRA ART system, an augmented respiration technology designed to rebalance patient oxygen saturation levels. This technology potentially allows patients...
-
Product Insights
Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Western Equine Encephalitis Drugs Development Market Report Overview Western equine encephalitis is a disease that is spread to humans by infected mosquitoes. Western equine encephalitis is caused by the western equine encephalitis virus, an arbovirus. Symptoms range from mild to severe and may include only fever and headache to encephalitis with delirium, disorientation, or coma. The western equine encephalitis pipeline drugs market research report provides comprehensive information on the therapeutics under development for western equine encephalitis, complete with analysis by...
-
Product Insights
Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, a tendency to bruise or bleed easily, ascites, impaired brain function (encephalopathy), poor weight gain and growth, fatigue, weakness, nausea, and loss of appetite. Since these symptoms are associated with a host of other conditions, it may take some time before the correct diagnosis is made. As liver failure...
-
Product Insights
Ornithine-Transcarbamylase Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ornithine transcarbamylase (OTC Deficiency) deficiency is a rare X-linked genetic disorder characterized by complete or partial lack of the enzyme ornithine transcarbamylase (OTC Deficiency). OTC Deficiency plays an important role in the break down and removal of nitrogen in the body (urea cycle). The lack of the OTC Deficiency enzyme results in excessive accumulation of nitrogen, in the form of ammonia (hyperammonemia), in the blood. Symptoms include vomiting, refusal to eat, progressive lethargy, and coma. The Ornithine-Transcarbamylase (OTC Deficiency) Deficiency...
-
Sector Analysis
Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
The Neuromodulation Devices pipeline market research report provides comprehensive information about the Neuromodulation Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.